Alliancebernstein L.P. Bluebird Bio, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 294,530 shares of BLUE stock, worth $94,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares

294,530

Previous 294,530 -0.0%

Holding current value

$94,249

Previous $288,000 46.88%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.85 - $1.26 $106,709 - $158,180	125,540 Added 74.29%	294,530 $288,000
Q4 2023 Feb 14, 2024	BUY	$1.32 - $4.83 $14,982 - $54,820	11,350 Added 7.2%	168,990 $233,000
Q2 2023 Aug 15, 2023	BUY	$2.79 - $5.03 $164,135 - $295,914	58,830 Added 59.54%	157,640 $518,000
Q1 2023 May 15, 2023	SELL	$3.14 - $8.22 $4,945 - $12,946	-1,575 Reduced 1.57%	98,810 $314,000
Q4 2022 Feb 14, 2023	SELL	$5.77 - $8.49 $120,015 - $176,592	-20,800 Reduced 17.16%	100,385 $694,000
Q3 2022 Nov 15, 2022	SELL	$3.75 - $7.39 $29,343 - $57,826	-7,825 Reduced 6.07%	121,185 $767,000
Q2 2022 Aug 15, 2022	BUY	$2.94 - $5.23 $225,439 - $401,036	76,680 Added 146.53%	129,010 $534,000
Q1 2022 May 13, 2022	SELL	$4.07 - $10.6 $51,689 - $134,620	-12,700 Reduced 19.53%	52,330 $254,000
Q4 2021 Feb 14, 2022	SELL	$8.96 - $16.31 $171,942 - $312,988	-19,190 Reduced 22.79%	65,030 $650,000
Q2 2021 Jul 30, 2021	BUY	$18.04 - $22.09 $1.12 Million - $1.37 Million	61,966 Added 278.45%	84,220 $2.69 Million
Q1 2021 May 06, 2021	SELL	$16.59 - $33.89 $168,985 - $345,203	-10,186 Reduced 31.4%	22,254 $671,000
Q4 2020 Feb 08, 2021	SELL	$27.5 - $37.92 $1.4 Million - $1.92 Million	-50,750 Reduced 61.0%	32,440 $1.4 Million
Q3 2020 Nov 12, 2020	BUY	$34.44 - $43.75 $1.77 Million - $2.24 Million	51,300 Added 160.87%	83,190 $4.49 Million
Q2 2020 Aug 13, 2020	SELL	$27.12 - $45.97 $1.16 Million - $1.97 Million	-42,750 Reduced 57.27%	31,890 $1.95 Million
Q1 2020 May 14, 2020	BUY	$26.16 - $63.5 $538,896 - $1.31 Million	20,600 Added 38.12%	74,640 $3.43 Million
Q4 2019 Feb 18, 2020	BUY	$46.96 - $61.67 $1.31 Million - $1.73 Million	28,000 Added 107.53%	54,040 $4.74 Million
Q3 2019 Nov 14, 2019	SELL	$59.47 - $93.1 $1.04 Million - $1.63 Million	-17,500 Reduced 40.19%	26,040 $2.39 Million
Q2 2019 Aug 14, 2019	BUY	$75.84 - $105.21 $714,412 - $991,078	9,420 Added 27.61%	43,540 $5.54 Million
Q1 2019 May 14, 2019	BUY	$64.44 - $104.11 $219,096 - $353,974	3,400 Added 11.07%	34,120 $5.37 Million
Q4 2018 Feb 13, 2019	SELL	$59.1 - $93.26 $16.6 Million - $26.3 Million	-281,500 Reduced 90.16%	30,720 $3.05 Million
Q3 2018 Nov 08, 2018	SELL	$88.86 - $117.49 $828,175 - $1.1 Million	-9,320 Reduced 2.9%	312,220 $45.6 Million
Q2 2018 Aug 13, 2018	BUY	$99.64 - $127.59 $3.72 Million - $4.76 Million	37,330 Added 13.13%	321,540 $50.5 Million
Q1 2018 May 14, 2018	BUY	$105.8 - $150.94 $20.3 Million - $29 Million	191,840 Added 207.69%	284,210 $48.5 Million
Q4 2017 Feb 13, 2018	BUY	$81.25 - $130.7 $1.05 Million - $1.7 Million	12,970 Added 16.34%	92,370 $16.5 Million
Q3 2017 Nov 13, 2017	BUY	$57.74 - $91.42 $4.58 Million - $7.26 Million	79,400	79,400 $10.9 Million

Others Institutions Holding BLUE

# of Institutions

152

Shares Held

63.7M

Call Options Held

264K

Put Options Held

428K

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $24.7M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. Bluebird Bio, Inc. Transaction History